Ligand validation:3NY9

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3NY9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NY9_OLC_A_1204	16%	52%	0.29	0.864	1.02	0.85	1	1	2	1	100%	1
3NY8_OLC_A_1206	19%	22%	0.266	0.865	1.72	1.51	2	3	0	1	100%	1
3D4S_OLC_A_405	18%	74%	0.263	0.847	0.41	0.6	-	-	0	0	100%	1
6PS2_OLC_A_1215	13%	65%	0.162	0.765	0.34	1	-	1	0	0	64%	0.64
6PS1_OLC_A_1206	9%	67%	0.266	0.805	0.42	0.86	-	2	1	0	72%	0.72
6PS3_OLC_A_1207	5%	62%	0.245	0.71	0.34	1.08	-	1	0	0	64%	0.64
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.